We determined that inactivation of promoter B in the osteosarcoma cell lines involves DNA methylation but also includes histone modifications, supporting the conclusion that the WNT5A alternative promoters are differentially regulated by epigenetic mechanisms in osteosarcoma tumors. The gene discussed is WNT5A; the disease is osteosarcoma.